Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Nvidia Stock Faces Critical Warning Sign. Is the AI Trade Breaking?

Nvidia Stock Faces Critical Warning Sign. Is the AI Trade Breaking?

BeInCryptoBeInCrypto2026/10/09 03:45
Nvidia stock fell 2.94% Thursday after OpenAI told investors its annualized revenue is roughly $50 billion, about $18 billion below the $68 billion widely reported last month. Alex Kantrowitz, founder of Big Technology, called the gap largely an accounting issue on CNBCs Closing Bell. Nvidia still closed at $230.48, about 5% below its Tuesday record high of $243.37. Why Is Nvidia Stock Taking the Hit for OpenAIs Number? Nvidia and Advanced Micro Devices (AMD) have each signed multibillion-dollar partnerships with OpenAI. Therefore, both chipmakers carry direct exposure to its growth. AMD slid 3.9% the same day. Oracle fell more than 5% in an OpenAI-linked stock crash. The interlinking between AI companies is showing as a number of stocks feel the impact of this issue. Source: Trading View Kantrowitz noted that both stocks have mostly performed well this year. Yahoo Finance data shows Nvidia up about 24%, with a market value near $5.6 trillion. Still, the fundamentals remain strong. Nvidia posted $96.22 billion in revenue last quarter, beating the $92.16 billion estimate, Google Finance data shows. However, Kantrowitz sees skittishness around the AI trade. He said some companies have shifted part of their spending to standard models rather than frontier ones. Can Nvidia Hold If OpenAI or Anthropic Stumbles? Kantrowitz said market breadth is weak, with the top seven stocks outpacing the other 493 in the SP 500. Meanwhile, a Closing Bell host put the tech trade at more than 40% of the market. Kantrowitz agreed the broader market hinges on OpenAI and Anthropic. In contrast, Wedbush analyst Dan Ives named Nvidia among his top five tech picks for 2027. He argued investors underestimate a $4 trillion AI spending wave. Kantrowitz expects Anthropics initial public offering (IPO) within weeks, most likely, and OpenAIs next year. The market is waiting for something to go wrong, he said, and any wrinkle could repeat Thursdays selloff or worse. Kantrowitz said Anthropics leaked S-1, a US listing filing, showed losses outpacing revenue gains. With two IPOs expected, filings could show whether AI revenue can carry the spending behind Nvidias valuation. Read the article at BeInCrypto
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - RBC expects gradual improvement in North American and European building materials stocks in the third quarter

October 9 - RBC expects the performance of most European building material products to gradually improve quarter-on-quarter in Q3, but notes that geopolitical uncertainties in the US will continue to drive up cost inflation and increase market volatility. RBC anticipates that sales in Europe will remain sluggish due to heatwaves and rising mortgage rates, while a weak US housing market and the lack of a significant hurricane season will prompt roofing material companies to enter a destocking cycle. The firm is more optimistic about Germany’s Heidelberg Group (HEIG.DE), upgrading its rating to “outperform,” and points out that the company has handled the challenging quarter caused by extreme weather far better than its peers. Due to severe cost headwinds such as rising diesel and natural gas prices, RBC downgraded the ratings of US and French construction companies Knife River (KNF.N) and Saint-Gobain (SGOB.PA) from “outperform” to “market perform.” (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translations may contain errors or lack necessary context, Reuters does not guarantee their accuracy and provides them solely for the ease of the reader. Reuters assumes no liability for any damages or losses that may arise from the use of automated translation functions.)

路透社•2026/10/09 07:16

3D printing materials supplier Amaero (AMRO.US) restarts US IPO, fundraising drops 60% to $20 million

Amaero (AMRO.US) on Thursday resumed its initial public offering (IPO) plans in the United States and filed new documents with the U.S. Securities and Exchange Commission (SEC), revealing a reduced number of shares to be issued.

智通财经•2026/10/09 07:11

Even with Eli Lilly's endorsement, TRex Bio (TRXB.US) struggles to enjoy a premium, as the issue price drops to the lower limit of $14.

Early-stage biotechnology company TRex Bio has priced its IPO at the lower end of the range at $14 per share, raising $116.7 million and achieving a market capitalization of $384 million. The company will be listed on Nasdaq on Friday, with Eli Lilly expressing interest in increasing its stake.

智通财经•2026/10/09 07:09

Small molecule biotechnology company Iambic Therapeutics (IAM.US) IPO priced at $15-17 per share, aiming to raise $150 millions.

Iambic Therapeutics plans to raise $150 millions by issuing 9.4 million shares, with an offering price range of $15 to $17 per share.

智通财经•2026/10/09 07:08